Meeting Type: Physical Dates: March 19 - 23, 2017 Location: Tahoe City, California , USA Intended Audience: Basic Scientist, Clinical Scientist, Physician in Practice, In Training and Early Career
Sponsor: Keystone Symposia on Molecular and Cellular Biology Purpose: Education, Scientific Number of CME Credits Offered: None
Diabetes, Endocrine Disruptors, Health Disparities, Lipids and Obesity, Mens Health, Neuroendocrinology, Womens Health
There are fundamental aspects of metabolic homeostasis that are regulated differently in males and females, and influence both the development of diabetes and obesity and the response to pharmacological intervention. Still, most preclinical researchers avoid studying female rodents due to the added complexity of research plans. The consequence is the generation of data that risks being relevant to only half of the population. This is a timely moment to study sex differences in diseases as NIH leadership has asked scientists to consider sex as a biological variable in preclinical research, to ensure that women get the same benefit of medical research as men. The goal of this meeting is to fill a need in the scientific community by connecting interdisciplinary groups of scientists who normally would not have an opportunity to interact. This group includes investigators studying sex differences, the role of sex hormones, the systems biology of sex and the genetic contribution of sex chromosomes to metabolic homeostasis and diseases. Leaders of the pharmaceutical industry will present their views on sex-specific drug discovery. The meeting is expected to generate new knowledge and ideas on the importance of gender biology and medicine from a molecular standpoint to the population level, and to provide the methods to study them. It is intended to be a catalyst of a process that will lead to gender-specific treatments of metabolic diseases.